Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Experience of Using Metformin in Patients Infected with HCV Genotype 3 with Concomitant Metabolic Disorders

Summary: The so-called “metabolic syndrome” is among the most significant factors that influence the natural course of Chronic Hepatitis C (CHC) and the effectiveness of specific Antiviral Therapy (AVT). Materials and methods: 34 patients with chronic hepatitis C (genotype 3) treated with standard AVT (PEGylated interferon in combination with ribavirin) were included in the study.

 

Citation: Golubovska OA, Gerasun BA, Shkurba AV, Kulyesh OV, Bezrodna OV (2015) Experience of Using Metformin in Patients Infected with HCV Genotype 3 with Concomitant Metabolic Disorders. Endocrinol Metab Synd 4:163. doi: 10.4172/2161-1017.1000163

  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger
Top